Why it was recalled
Lack of Assurance of Sterility
Product description
Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-03.
Lot numbers, UPCs & expiration codes
Lot 240709, exp 7/31/2026
Where it was sold
OH
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0394-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Feb 26, 2026
- FDA report date
- Mar 11, 2026
- Quantity
- 23 vials
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- New Life Pharma LLC
Original FDA data
Every field from FDA enforcement report D-0394-2026, exactly as published.
Show all FDA fields
- City
- Northvale
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 98496
- Address
- 265 Livingston St
- Code information
- Lot 240709, exp 7/31/2026
- Postal code
- 07647-1901
- Report date
- Mar 11, 2026
- Product type
- Drugs
- Recall number
- D-0394-2026
- Classification
- Class II
- Recalling firm
- New Life Pharma LLC
- Product quantity
- 23 vials
- Reason for recall
- Lack of Assurance of Sterility
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-03.
- Distribution pattern
- OH
- Recall initiation date
- Feb 26, 2026
- Initial firm notification
- Letter
- Center classification date
- Mar 17, 2026